Geode Capital Management’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$64.2K Buy
169,025
+2,812
+2% +$1.07K ﹤0.01% 4160
2025
Q1
$173K Buy
166,213
+6,806
+4% +$7.08K ﹤0.01% 3891
2024
Q4
$156K Sell
159,407
-3,835
-2% -$3.75K ﹤0.01% 3971
2024
Q3
$240K Buy
163,242
+14,199
+10% +$20.9K ﹤0.01% 3850
2024
Q2
$201K Buy
149,043
+14,910
+11% +$20.1K ﹤0.01% 3907
2024
Q1
$220K Buy
134,133
+2,351
+2% +$3.86K ﹤0.01% 3910
2023
Q4
$254K Hold
131,782
﹤0.01% 3856
2023
Q3
$316K Buy
131,782
+5,674
+4% +$13.6K ﹤0.01% 3792
2023
Q2
$322K Buy
126,108
+3,125
+3% +$7.97K ﹤0.01% 3826
2023
Q1
$200K Buy
122,983
+31,882
+35% +$52K ﹤0.01% 4050
2022
Q4
$249K Buy
91,101
+49,004
+116% +$134K ﹤0.01% 3973
2022
Q3
$166K Buy
42,097
+333
+0.8% +$1.31K ﹤0.01% 4314
2022
Q2
$235K Sell
41,764
-213
-0.5% -$1.2K ﹤0.01% 4166
2022
Q1
$470K Buy
41,977
+7,374
+21% +$82.6K ﹤0.01% 3962
2021
Q4
$505K Buy
34,603
+2,736
+9% +$39.9K ﹤0.01% 4039
2021
Q3
$956K Buy
31,867
+1,242
+4% +$37.3K ﹤0.01% 3700
2021
Q2
$1.42M Sell
30,625
-24,887
-45% -$1.15M ﹤0.01% 3430
2021
Q1
$3.33M Buy
55,512
+8,685
+19% +$521K ﹤0.01% 2985
2020
Q4
$2.45M Buy
46,827
+1,779
+4% +$93.2K ﹤0.01% 2971
2020
Q3
$1.56M Sell
45,048
-1,508
-3% -$52.2K ﹤0.01% 3009
2020
Q2
$4.04M Buy
46,556
+6,389
+16% +$555K ﹤0.01% 2455
2020
Q1
$2.33M Buy
40,167
+4,532
+13% +$263K ﹤0.01% 2590
2019
Q4
$2.57M Buy
35,635
+2,795
+9% +$201K ﹤0.01% 2856
2019
Q3
$2M Buy
32,840
+12,750
+63% +$778K ﹤0.01% 2940
2019
Q2
$1.91M Buy
20,090
+3,200
+19% +$304K ﹤0.01% 2984
2019
Q1
$1.37M Buy
16,890
+2,341
+16% +$190K ﹤0.01% 3036
2018
Q4
$2.37M Buy
14,549
+8,752
+151% +$1.42M ﹤0.01% 2681
2018
Q3
$944K Buy
5,797
+168
+3% +$27.4K ﹤0.01% 3244
2018
Q2
$847K Buy
+5,629
New +$847K ﹤0.01% 3249